LH — LABCORP HOLDINGS INC.
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 920148 ·
Last close
$309.20
Market Cap
$25.35B
52W High
$316.11
52W Low
$247.91
ADV30
780,748
Next earnings
2026-07-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 3,537,600,000 | 1,013,800,000 | 387,200,000 | 277,800,000 | 19,087,100,000 | 981,100,000 | 10,341,600,000 |
| Dec 2025 | 3,515,800,000 | 993,200,000 | 382,000,000 | 164,700,000 | 18,392,700,000 | 532,300,000 | 9,756,000,000 |
| Sep 2025 | 3,563,500,000 | 1,025,100,000 | 403,200,000 | 261,100,000 | 18,261,600,000 | 598,100,000 | 9,548,600,000 |
| Jun 2025 | 3,527,300,000 | 1,046,200,000 | 398,600,000 | 237,900,000 | 18,059,900,000 | 647,300,000 | 9,570,500,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,813,500,000
Investing CF
$-1,180,100,000
Financing CF
$-36,800,000
CapEx
$-429,500,000
Dividends Paid
$-240,300,000
Buybacks
$-548,000,000
EPS Diluted TTM
$11.29
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$8,784,400,000
Inventory
$497,700,000
Receivables
$2,450,500,000
ST Investments
—
EBIT TTM
$1,375,200,000
Pretax Income TTM
$1,152,000,000
Interest Exp TTM
$223,200,000
Analysts
17
Yahoo Snapshot (yfinance, live)
Total Revenue
$14,348,000,256
EBITDA
$2,319,800,064
Free Cash Flow
$892,049,984
Enterprise Value
$32,167,077,888
Total Cash
$141,800,000
Total Debt
$6,766,099,968
Shares Out
82,000,000
Trailing EPS
$12.08
Book Value
$106.06
ROE
11.7%
ROA
5.5%
Div Yield
0.91%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 13,951,700,000 | 1,516,200,000 | 876,500,000 | 18,392,700,000 | 9,756,000,000 | — | 1,640,500,000 |
| Dec 2024 | 13,008,900,000 | 1,138,000,000 | 746,000,000 | 18,379,000,000 | 10,312,500,000 | — | 1,585,800,000 |
| Dec 2023 | 12,161,600,000 | 1,123,700,000 | 418,000,000 | 16,725,100,000 | 8,834,600,000 | — | 1,327,700,000 |
| Dec 2022 | 11,863,900,000 | 1,752,200,000 | 1,279,100,000 | 20,155,100,000 | 10,039,600,000 | — | 1,955,900,000 |
TTM Snapshot
Revenues TTM
$13,268,200,000
NetIncome TTM
$1,292,700,000
OpCashFlow TTM
$0
Assets (Latest)
$18,379,000,000
Forward EPS
$19.46
Max Pain — expiry 2026-08-21
max pain strike: $260.00 · spot: $309.20 · call oi: 1,171 · put oi: 422Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DGX | QUEST DIAGNOSTICS INC | $25.72B | $233.01 | — |
| GH | Guardant Health, Inc. | $21.48B | $161.99 | — |
| THC | TENET HEALTHCARE CORP | $20.51B | $254.78 | — |
| NTRA | Natera, Inc. | $38.35B | $267.76 | — |
| DVA | DAVITA INC. | $15.41B | $240.09 | — |
News headlines (Yahoo Finance, 1h cache)
Labcorp (LH) Launches Marker Genetic Health Panel For Consumer Testing
2026-07-31 23:08 · Yahoo
LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase
2026-07-31 22:59 · Yahoo
Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?
2026-07-31 14:06 · Yahoo
Labcorp Q2 Earnings Call Highlights
2026-07-31 12:03 · Yahoo
Labcorp Holdings Inc. Q2 2026 Earnings Call Summary
2026-07-31 02:20 · Yahoo
Labcorp (LH) Q2 2026 Earnings Call Transcript
2026-07-31 01:47 · Yahoo
Is The Sharp Drop In Hims & Hers Health Stock A Reason To Buy?
2026-07-30 21:38 · Yahoo
Labcorp Holdings Inc (LH) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...
2026-07-30 21:08 · Yahoo
Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026
2026-07-30 16:34 · Yahoo
LH Stock Down Despite Q2 Earnings and Revenue Beat, Margins Rise
2026-07-30 15:29 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.